Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the stock has risen by around just 3%. This is not the type of investment ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Hers breaks down the winter blues, what causes them, and research-backed tips for handling this seasonal mood change.

Legislation to create a program for the medicinal use of psilocybin was introduced today in the New Mexico Senate. Senate Bill 219, the Medical Psilocybin Act, would allow those in New Mexico to ...

Antidepressants, such as Prozac, are already used to treat the condition but Canadian and Italian scientists set out to ...

Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.

(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced two ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The scientific literature has highlighted the role of inflammation in major depressive disorder (MDD), permeating several states of the disease. In chronic ...

The phrase 'You are what you eat' derives from a pioneering French food critic who, 200 years ago, published a bestseller ...

A new study, led by USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI), will explore structural ...

Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder.